COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

RSS icon
Thumbnail

Trump administration ups COVID-19 enforcement against nursing homes

CMS is increasing enforcement, including civil penalties, against nursing homes with persistent infection control violations for COVID-19. 

Thumbnail

27% of Americans would reject COVID-19 vaccine

Just 7 in 10 Americans said they would get a vaccine to protect against COVID-19, according to an ABC News/Washington Post poll, with 15% of adults saying they definitely and 12% saying they probably would not get the vaccine.

Thumbnail

Cancer patients with COVID-19 have higher risk of death

Cancer patients also diagnosed with COVID-19 are much more likely to die compared to the general public, according to a new study published in The Lancet.

Thumbnail

Healthcare companies are returning COVID-19 relief funds

Some major healthcare companies, including DaVita, Cigna, Encompass, CVS Health and Walmart, are sending back federal aid funding they received that was intended to help hospitals and healthcare providers during the COVID-19 pandemic.

Thumbnail

US surpasses 100,000 COVID-19 deaths

The U.S. hit a new milestone in the COVID-19 pandemic, surpassing 100,000 deaths caused by the virus––more than anywhere else on Earth.

Thumbnail

Testing AL and nursing homes for COVID-19 would cost $672M

Testing the combined residents of the nation’s assisted living facilities and nursing homes would cost a whopping $672 million for just one round of testing.

Thumbnail

North Dakota has the best health infrastructure during the COVID-19 pandemic

WalletHub compared the 50 states on 14 unique metrics to determine which had the best health infrastructures to deal with the COVID-19 pandemic.

Thumbnail

Biopharma may not come out on top from COVID-19 pandemic

While emerging conventional wisdom may state biopharmaceutical companies could see a boon as a result of the COVID-19 pandemic thanks to new treatment and vaccine opportunities, the sector may not come out on top.

Displaying 361 - 368 of 403

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”